SPRINT BIOSCIENCE

Sprint Bioscience is a pharmaceutical company focused on developing innovative drug candidates that can contribute to new treatments for cancer. The great need for new treatments for difficult-to-treat cancer brings great commercial potential. Using a fragment-based drug development approach, we develop drug programs in a time- and resource-efficient manner that are out-licensed to global pharmaceutical companies during the preclinical phase. Sprint Bioscience has successfully entered into several global license agreements with pharmaceutical companies. These companies resource and develop the programs further into finished drugs that can be brought to market and help patients who are in dire need of new treatment options.

Also known as: Sprint Bioscience AB, Sprint Bioscience AB (publ)

Registration numbers: 556789-7557 (W)